VHL and neoplasm: In those studies, only overexpression of FIH-insensitive HIF2a in T cells resulted in improved anti-tumour control; VHL- and FIH-insensitive HIF2 in T cells circulate in the periphery to a lesser extent and do not significantly improve anti-tumour control when compared to T cells transduced with a control vector (9).